Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Le

Showing results (231-240 of 287) with videos related to

Pageof 29
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2017
Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trialsJennifer Le-Rademacher, Rahul Kanwar, Drew Seisler, et al.
Frontiers in Oncology|December 13, 2023
A deep learning model to generate synthetic CT for prostate MR-only radiotherapy dose planning: a multicenter studySafaa Tahri, Blanche Texier, Jean-Claude Nunes, et al.
The Oncologist|June 7, 2023
Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)Rudolph M Navari, Jennifer Le-Rademacher, Fabrice Smieliauskas, et al.
Blood|October 6, 2021
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trialsCarla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 12, 2018
Preliminary Development of the Food Allergy Coping and Emotions Questionnaires for Children, Adolescents, and Young People: Qualitative Analysis of Data on IgE-Mediated Food Allergy from Five CountriesAudrey DunnGalvin, Laura Polloni, Jennifer Le Bovidge, et al.
Bone Marrow Transplantation|November 20, 2019
Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adultsNavneet S Majhail, Lih-Wen Mau, Pintip Chitphakdithai, et al.
Breast (Edinburgh, Scotland)|March 21, 2020
Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: A pilot studyTeresa M Salgado, Jin Liu, Holly L Reed, et al.
Frontiers in Public Health|March 20, 2026
Transforming long-term post-acute care for the aging population through home infusion therapy in China: assurance for quality and safety of care delivery (Part 2)Wei Zuo, Zi Yin Zhou, Kayla Huynh, et al.
Journal of the American Chemical Society|June 6, 2026
Room-Temperature Viscoelastic Liquid Semiconducting Block Copolymer with Mixed Ionic-Electronic ConductionRachel Blau, Yi Qie, Roxane Cayrat, et al.
Cancer|October 7, 2015
Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)William A Wood, Jennifer Le-Rademacher, Karen L Syrjala, et al.
Pageof 29

Showing results (231-240 of 287) with videos related to

Sort By:
Pageof 29
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2017
Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trialsJennifer Le-Rademacher, Rahul Kanwar, Drew Seisler, et al.
Frontiers in Oncology|December 13, 2023
A deep learning model to generate synthetic CT for prostate MR-only radiotherapy dose planning: a multicenter studySafaa Tahri, Blanche Texier, Jean-Claude Nunes, et al.
The Oncologist|June 7, 2023
Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)Rudolph M Navari, Jennifer Le-Rademacher, Fabrice Smieliauskas, et al.
Blood|October 6, 2021
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trialsCarla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 12, 2018
Preliminary Development of the Food Allergy Coping and Emotions Questionnaires for Children, Adolescents, and Young People: Qualitative Analysis of Data on IgE-Mediated Food Allergy from Five CountriesAudrey DunnGalvin, Laura Polloni, Jennifer Le Bovidge, et al.
Bone Marrow Transplantation|November 20, 2019
Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adultsNavneet S Majhail, Lih-Wen Mau, Pintip Chitphakdithai, et al.
Breast (Edinburgh, Scotland)|March 21, 2020
Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: A pilot studyTeresa M Salgado, Jin Liu, Holly L Reed, et al.
Frontiers in Public Health|March 20, 2026
Transforming long-term post-acute care for the aging population through home infusion therapy in China: assurance for quality and safety of care delivery (Part 2)Wei Zuo, Zi Yin Zhou, Kayla Huynh, et al.
Journal of the American Chemical Society|June 6, 2026
Room-Temperature Viscoelastic Liquid Semiconducting Block Copolymer with Mixed Ionic-Electronic ConductionRachel Blau, Yi Qie, Roxane Cayrat, et al.
Cancer|October 7, 2015
Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)William A Wood, Jennifer Le-Rademacher, Karen L Syrjala, et al.
Pageof 29